Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $124.52. The company's market cap stands at 307.27B, with a P/E ratio of 35.92 and a dividend yield of 2.63%.
On 2026-07-21, Merck(MRK) stock traded between a low of $124.40 and a high of $124.93. Shares are currently priced at $124.52, which is +0.1% above the low and -0.3% below the high.
Merck(MRK) shares are trading with a volume of 14.83K, against a daily average of 9.19M.
During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $131.74 at its peak.
During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $131.74 at its peak.
MRK News
...
Biotech and Pharma Merck’s Keytruda Faces a Patent Cliff. These New Cancer Drugs Could Take Over. In this article MRK BMY PFE AMGN JNJ The next standard cancer...
With inflation and interest-rate expectations pulled in different directions by oil prices, geopolitics, and uneven growth data, a lot of stocks are being price...
Analyst ratings
66%
of 29 ratingsMore MRK News
Biotech and Pharma What Comes After Merck’s Keytruda? The Race for the Next Standard Cancer Treatment. In this article MRK BMY AZN SMMT ROP The next standard ca...
With inflation trends, interest rates and energy prices all pulling markets in different directions, reliable cash generation has become a key focus for many in...
Merck stock has delivered a strong 92.2% return over the past 5 years, yet its current valuation picture is mixed, with the Discounted Cash Flow (DCF) intrinsic...
Merck (NYSE:MRK) has received FDA approval for Lipfendra, the first once daily oral PCSK9 inhibitor for lowering LDL cholesterol. Lipfendra offers an oral alte...
Technology Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies. Licensing Personalis (PSNL) stock popped Friday on a rumor Merck (MRK) and at...
Personalis (PSNL) shares added ~4% in the premarket on Friday following a report indicating that the company is exploring a potential sale after receiving takeo...
Needham raised the firm’s price target on Personalis (PSNL) to $17 from $12 and keeps a Buy rating on the shares following a blog report that the company has re...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.